ImmunologybioRxiv
Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19
A. Vitelli, S. Capone, A. Raggioli…·S. Colloca
This paper evaluates a gorilla adenovirus vaccine candidate for COVID-19, showing it is immunogenic in mice and macaques and supports its advancement to a Phase I clinical trial.
DOI 10.1016/j.ymthe.2021.04.022